The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
1
|
V | Various | |
2
|
V09 | Diagnostic radiopharmaceuticals | |
3
|
V09H | Inflammation and infection detection |
| Code | Title | |
|---|---|---|
| V09HA | Technetium (99mTc) compounds | |
| V09HB | Indium (111In) compounds | |
| V09HX | Other diagnostic radiopharmaceuticals for inflammation and infection detection |
| Active Ingredient |
|---|
|
Indium forms a saturated (1:3) complex with oxyquinoline. The complex is neutral and lipid-soluble, which enables it to penetrate the cell membrane. It is thought likely that the mechanism of labeling cells with indium In-111 oxyquinoline involves an exchange reaction between the oxyquinoline carrier and subcellular components which chelate indium more strongly than oxyquinoline. |
|
Technetium ⁹⁹ᵐTc sulesomab (IMMU-MN3 murine Fab′-SH antigranulocyte monoclonal antibody fragments) recognizes an antigenic structure shared by a surface glycoprotein (NCA-90) of granulocytes and the tumour marker. It is indicated for diagnostic imaging for determining the location and extent of infection/inflammation in bone in patients with suspected osteomyelitis, including patients with diabetic foot ulcers. |
| Document | Type | Information Source | |
|---|---|---|---|
| LEUKOSCAN Powder for solution for injection | MPI, EU: SmPC | European Medicines Agency (EU) | |
| SCINTIMUN Kit for radiopharmaceutical preparation | MPI, EU: SmPC | European Medicines Agency (EU) |